Literature DB >> 27868108

Inflammatory monocytes hinder antiviral B cell responses.

Stefano Sammicheli1, Mirela Kuka1, Pietro Di Lucia2, Nereida Jimenez de Oya2, Marco De Giovanni1, Jessica Fioravanti2, Claudia Cristofani1, Carmela G Maganuco1, Benedict Fallet3, Lucia Ganzer2, Laura Sironi2, Marta Mainetti2, Renato Ostuni4, Kevin Larimore5, Philip D Greenberg5, Juan Carlos de la Torre6, Luca G Guidotti2, Matteo Iannacone7.   

Abstract

Antibodies are critical for protection against viral infections. However, several viruses, such as lymphocytic choriomeningitis virus (LCMV), avoid the induction of early protective antibody responses by poorly understood mechanisms. Here we analyzed the spatiotemporal dynamics of B cell activation to show that, upon subcutaneous infection, LCMV-specific B cells readily relocate to the interfollicular and T cell areas of the draining lymph node where they extensively interact with CD11b+Ly6Chi inflammatory monocytes. These myeloid cells were recruited to lymph nodes draining LCMV infection sites in a type I interferon-, CCR2-dependent fashion and they suppressed antiviral B cell responses by virtue of their ability to produce nitric oxide. Depletion of inflammatory monocytes, inhibition of their lymph node recruitment or impairment of their nitric oxide-producing ability enhanced LCMV-specific B cell survival and led to robust neutralizing antibody production. In conclusion, our results identify inflammatory monocytes as critical gatekeepers that prevent antiviral B cell responses and suggest that certain viruses take advantage of these cells to prolong their persistence within the host.

Entities:  

Year:  2016        PMID: 27868108      PMCID: PMC5111729          DOI: 10.1126/sciimmunol.aah6789

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  44 in total

1.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

2.  Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.

Authors:  Tobias Junt; E Ashley Moseman; Matteo Iannacone; Steffen Massberg; Philipp A Lang; Marianne Boes; Katja Fink; Sarah E Henrickson; Dmitry M Shayakhmetov; Nelson C Di Paolo; Nico van Rooijen; Thorsten R Mempel; Sean P Whelan; Ulrich H von Andrian
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

3.  B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node.

Authors:  Yolanda R Carrasco; Facundo D Batista
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

4.  Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].

Authors:  O Planz; P Seiler; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

5.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

6.  Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue.

Authors:  Norifumi Iijima; Lisa M Mattei; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 7.  Antiviral antibody responses: the two extremes of a wide spectrum.

Authors:  Lars Hangartner; Rolf M Zinkernagel; Hans Hengartner
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

8.  B cell receptor signal strength determines B cell fate.

Authors:  Stefano Casola; Kevin L Otipoby; Marat Alimzhanov; Sibille Humme; Nathalie Uyttersprot; Jeffery L Kutok; Michael C Carroll; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

9.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

Review 10.  Immune suppressive mechanisms in the tumor microenvironment.

Authors:  David H Munn; Vincenzo Bronte
Journal:  Curr Opin Immunol       Date:  2015-11-21       Impact factor: 7.486

View more
  45 in total

1.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

Review 2.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

3.  Infection: Interferons suppress antibody responses.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

4.  IL-12 Blocks Tfh Cell Differentiation during Salmonella Infection, thereby Contributing to Germinal Center Suppression.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

5.  The Suppressive Attitude of Inflammatory Monocytes in Antiviral Antibody Responses.

Authors:  Eleonora Sala; Mirela Kuka
Journal:  Viral Immunol       Date:  2020-02-06       Impact factor: 2.257

Review 6.  The role of type I interferons in CD4+ T cell differentiation.

Authors:  Mirela Kuka; Marco De Giovanni; Matteo Iannacone
Journal:  Immunol Lett       Date:  2019-02-13       Impact factor: 3.685

Review 7.  In vivo imaging of adaptive immune responses to viruses.

Authors:  Marco De Giovanni; Matteo Iannacone
Journal:  Curr Opin Virol       Date:  2017-12-26       Impact factor: 7.090

8.  Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq.

Authors:  Chiara Medaglia; Amir Giladi; Liat Stoler-Barak; Marco De Giovanni; Tomer Meir Salame; Adi Biram; Eyal David; Hanjie Li; Matteo Iannacone; Ziv Shulman; Ido Amit
Journal:  Science       Date:  2017-12-07       Impact factor: 47.728

9.  Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model.

Authors:  Ran He; Xinxin Yang; Cheng Liu; Xiangyu Chen; Lin Wang; Minglu Xiao; Jianqiang Ye; Yuzhang Wu; Lilin Ye
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

10.  Lymph node stromal CCL2 limits antibody responses.

Authors:  Dragos C Dasoveanu; Hyeung Ju Park; Catherine L Ly; William D Shipman; Susan Chyou; Varsha Kumar; David Tarlinton; Burkhard Ludewig; Babak J Mehrara; Theresa T Lu
Journal:  Sci Immunol       Date:  2020-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.